Dubai Final-v20.indd - World Allergy Organization

ABstrACts
ABstrACts
treated with a relevant Oit protocol for nFA. As a control group 10 subjets received only iFn-gamma without allergenic food. 10
subjets receive only food without iFn-gamma, and 20 subjets with nFA did not receive treatment. Patients were evaluated clinically
after treatment using subcutaneous iFn-gamma injection.
results: All patients became successfully tolerized to previously offensive foods (changes in clinical severity scores by food
challenge from 15.9 ± 3.6 to 1.8 ± 1.0 points, p 0.05) in a group of only iFn-gamma treatment
without food, from 14.6 ± 3.6 to 14.1 ± 3.0 points (p>0.05) in a group of only food challenge without iFn-gamma treatment, and
from 15.9 ± 3.7 to 15.4 ± 4.3 points (p >0.05) in a untreated group with neither iFn-gamma nor food.
Conclusions: non-igE-mediated food allergy can be successfully treated by relevant oral immunotherapy using iFn-gamma. iFngammaƒnseemed
to be necessary for the tolerance induction.
3210
THE rolE oF immUnoTHEraPY in aSTHma anD rHiniTiS
Hwejeh, l.
Chest Department, AlAsAD UniVErsitY HOsPitAl in DAmAsCUD, Damascus, syria.
immunotherapy (sit ) is the only currently available treatment that deals with the main cause of allergic disease by modifying the
immune response
Our study is a retrospective study in alasad university hospital in Damascus syria to identify the causative allergens and to evaluate
the efficacy of immunotherapy .
We studied 345 patients with well-documented history of rhinitis(68%) , or asthma (47%).
140 patients received either sublingual or subcutaneous immune therapy and followed the protocol of sit.
results showed 65.9% improvement in asthmatic patients with pollen allergy ,
And 78% improvement in asthmatic patients with mites allergy.
Patients with rhinitis due to mites allergy had 76.4% improvement
While patients with rhinitis allergic to pollen had 70.1% improvement
3211
CHroniC aSTHma in aDUlTS
Aguilar, D.
mEDiCinE DiVisiOn, JUArEZ HOsPitAl, mexico DF, mexico.
Alterations of forced vital capacity (FVC) and one-second forced expiratory volume (FEV1) forms part of the alterations present
in chronic asthma. in an area that is aggressive for the health of the asthmatic patients as the city of mexico for its height, air
pollution, overpopulation and migratory flows, the evolution of this disease to be different to other people living in other places
with characteristics less damaging their environment. We used spirometry system to study 50 patients staying more than 5 years
in the Valley of mexico
with diagnosis of moderate persistent asthma. measurmenet made to that end of the values of FVC and FEVi in early morning
without using bronchodilators and steroids systemic or topical. statistic : missing system. results: 35 females and 15 males,
aged between 18 and 81 years old standard dev, in female 12.91, mean 39, standard dev. in male: 13.44, mean 35.5. He won
the following most common pattern: Bronchial Hyperreactivity+ normal spirometry 39% in females. male sex in the peripheral
moderate obstruction+ bronchial hyrresponsiveness in 33%. Conclusion: in both sexes the prevalence is the obstruction from mild,
moderate and severe. most patients had bronchial hyperreactivity.
3212
SUBCUTanEoUS immUnoTHEraPY For TrEE PollEn allErgY WiTH a PrEParaTion WiTH oPTimiSED allErgEn
alUminiUm HYDroXiDE raTio: an oPEn laBEl oBSErVaTional STUDY inVESTigaTing TolEraBiliTY anD
EFFECTiVEnESS in THE roUTinE USE in DailY PraCTiSE
neumann, U. 1 , Wolf, H. 2 , schnitker, J. 3 and Wuestenberg, E. g. 4
1 2 3 Ent-Physician, Wolmirstedt, germany. Clinical Development, AlK-Abelló, Wedel, germany. institut für angewandte statistik,
Bielefeld, germany. 4medical and regulatory Affairs, AlK-Abelló, Wedel, germany.
Background: For subcutaneous immunotherapy (sCit) allergens usually are adsorbed to aluminium hydroxide (alum) for slow
www.worldallergy.org 150
FinAl PrOgrAm